Remote monitoring costs, benefits, and reimbursement: A European perspective

Europace

Volumn 15, Issue SUPPL.1, 2013, Pages

  Chronaki, Catherine E ^a   Vardas, Panos ^b  

^a INSTITUTE OF COMPUTER SCIENCE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cardiac implantable electronic devices; Cost effectiveness; Reimbursement; Remote follow up; Remote monitoring

Indexed keywords

ARTICLE; AUSTRIA; CARDIAC RESYNCHRONIZATION THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ELECTRONIC MEDICAL RECORD; GERMANY; HEALTH CARE COST; HOME MONITORING; HUMAN; IMPLANTED HEART PACEMAKER; ITALY; MEDICATION COMPLIANCE; NETHERLANDS; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; SPAIN; UNITED KINGDOM;

CARDIAC IMPLANTABLE ELECTRONIC DEVICES; COST-EFFECTIVENESS; REIMBURSEMENT; REMOTE FOLLOW-UP; REMOTE MONITORING;

COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; EQUIPMENT FAILURE ANALYSIS; EUROPE; HEALTH CARE COSTS; INSURANCE, HEALTH, REIMBURSEMENT; PACEMAKER, ARTIFICIAL; PRODUCT SURVEILLANCE, POSTMARKETING; TELEMEDICINE;

EID: 84878899177     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut110     Document Type: Article

References (46)

1. European Commission, Economic and National Affairs. The 2012 Ageing Report: Underlying Assumptions and Projection Methodologies European Economy, 2011, p. 54. http://europa.eu/epc/pdf/2012-ageing-report-en.pdf (5 March 2013
2. Lozano R, Naghavi M, Foreman K. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
3. Leal J, Luengo-Fernandez R, Gray A. Economic costs. In: Nichols M, Townsend N, Scarborough P, Rayner M et al. (eds.) European Cardiovascular Disease Statistics 2012. Sophia Antipolis: European Heart Network, Brussels, European Society of Cardiology. http://www.ehnheart.org/downloads/1436.html (4 March 2013 date last accessed).
4. Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP et al. Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe-The EURIKA Study. BMC Public Health 2011;11:704.
5. Elmqvist R. Review of early pacemaker development. Pacing Clin Electrophysiol 1978; 1:535-6.
6. Epstein AE, Dimarco JP, Elenbogen KA, EstesNA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008;5:934-55.
7. Eucomed: Statistics for cardiac rhythm management products, 2005-2011. http ://www.eucomed.org/uploads/-medical-technology/facts-figures/ 20120606-statistics-for-cardiac-rhythm-management-products-20052011.pdf (4 March 2013 date last accessed).
8. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM et al. HRS/ EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations. Europace 2008;10:707-25.
9. Furman S, Parker B, Escher DJ. Trans-telephone pacemaker clinic. J. Thorac Cardiovasc Surg 1971;61:827-34.
10. PriceWaterCoopers for Eucomed. Moving towards good practices in the reimbursement of CIED monitoring. 2012. http://www.eucomed.org/uploads/ Modules/Publications/whitepaper-reimbursementciedtelemonitoring.pdf (1
11. Varma N, Epstein AE, Irimpen A, Schweikert R, LoveC,TRUSTInvestigators. Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Followup (TRUST) trial. Circulation 2010;122:325-32.
12. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: Analysis of a worldwide database. Pacing Clin Electrophysiol 2007;30(Suppl. 1):S2-12.
13. Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A et al. A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). Eur Heart J 2012;33:1105-11.
14. Landolina M, Perego GB, LunatiM et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012;125:2985-92.
15. Wetzel U, Geller C, Kautzner J, Moertel H, Schumacher B, TaborskyMet al. Remote follow-up for ICD-therapy in patients meeting Madit II criteria. The REFORM trial (abstract). Heart Rhythm 2009;6:S259.
16. Elsner CH, Sommer P, Piorkowski C, Taborsky M, Neuser H, Bytesnik J et al. A prospective multicenter comparison trial of home monitoring against regular follow-up in MADIT II patients: Additional visits and cost impact. Comput Cardiol 2006;33: 241-4.
17. Fauchier L, Sadoul N, Kouakam C, Briand F, Chauvin M, BabutyDet al. Potential cost savings by telemedicine-assisted long-termcare of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2005;28(Suppl. 1):S255-9.
18. Raatikainen MJ, Uusimaa P, van Ginneken MM, Janssen JP, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: A safe, time-saving, and cost-effective means for follow-up. Europace 2008;10:1145-51.
19. Varma N, Pavri BB, Stambler B, Michalski J, TRUSTInvestigators. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUSTremote monitoring trial: Influence of contrasting messaging systems. Europace 2013;15:697-703.
20. Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 2012;14:278-93.
21. CrossleyGH, Boyle A, Vitense H, ChangY,MeadRHet al.,CONNECTinvestigators. TheCONNECT(Clinical Evaluation of remote Notification to Reduce Time to Clinical Decision) Trial: The value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011;57:1181-9.
22. Mabo P, Inserm R, Defaye P, Davy JM, Deharo JC, Kacet S et al., EVATEL: Remote follow-up of patients implanted with an ICD: The prospective randomized EVATEL study. ESC Congress report, presented at ESC2011, Paris, 27-31 August 2011. http://spo.escardio.org/eslides/view.aspx?eevtid=48&fp=2173 (15 March 2013
23. Guedon-Moreau L, Lacroix D, Sadoul N, Clémenty J, Kouakam C, Hermida JS et al.A randomized study of remote follow-up of implantable cardioverter defibrillators: Safety and efficacy report of the ECOST trial. Eur Heart J 2013;34:605-14.
24. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M et al. Long term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. Circulation 2010;122:2359-67.
25. Boriani G, Biffi M, Marziali A, Diemberger I, Martignani C. A changing scenario in the clinical use of implantable defibrillators: The need for long-term data on lead performance. Europace 2009;11:1-3.
26. Kleemann T, BeckerT, Doenges K, Vater M, Senges J, Schneider S et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of .10 years. Circulation 2007;115:2474-80.
27. Theuns DA, Jordaens L. Use of remote monitoring in the management of systemrelated complications in implantable defibrillator patients. Neth Heart J 2012;20: 82-5.
28. Ricci RP, Morichelli L, Quarta L, Sassi A, Porfili A, Laudadio MT et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 2010;12:674-9.
29. Gramegna L, Tomasi C, Gasparini G, Scaboro G, Zanon F, Boaretto G et al. In-hospital follow-up of implantable cardioverter defibrillator and pacemaker carriers: Patients? inconvenience and points of view.A four-hospital Italian survey. Europace 2012;14:345-50.
30. Simmers TA. Remote care: Bidding our ICD patients a fond farewell? Neth Heart J 2012;20:71-6.
31. Petersen HH, Larsen MC, NielsenOW, Kensing F, Svendsen JH. Patient satisfaction and suggestions for improvement of remote ICD monitoring. J Interv Card Electrophysiol 2012;34:317-24.
32. Braunschweig F, Boriani G, Bauer A, Hatala R, Herrmann-Lingen C, Kautzner J et al. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. Europace 2010;12: 1673-90.
33. de Cock CC, Elders J, van Hemel NM, van Den Broek K, van Erven L, de Mol B et al. Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands: An expert consensus report of the Netherlands Society of Cardiology. Neth Heart J 2012;20:53-65.
34. Ricci RP,Calcagnini G, CastroA, Giada F, Igidbashan D, LandolinaMet al. Consensus document on remote monitoring of cardiac implantable device technology, indications, organizational models, acceptability, responsibility and economic issues. J Ital Cardiol 2011;12:450-67.
35. Fuhrer J, Babotai I, Bauersfeld U. Recommandations pour la télésurveillance des implants à buts diagnostiques et thérapeutiques lors d?arythmies et d?insuffisance cardiaque. Cardiovasc Med 2011;14:58-60.
36. Heart Rhythm UK. Standards for implantation and follow-up of cardiac rhythm management devices in adults. 2013. http://heartrhythmuk.org.uk/files/ file/Docs/ Position%20Statements/121214-1- Heart%20Rhythm%20UK%20standards%20for%20CRM%20devices%20in%20adults%202013.pdf (13 March 2013 date last accessed).
37. Halimi F, Cantù F, on behalf of EHRA SIC. Remote monitoring for active cardiovascular implantable electronic devices: A European survey. Europace 2010;12: 1778-80.
38. Marinskis G, van Erven L, Bongiorni MG, Lip GY, Pison L, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Practices of cardiac implantable electronic device follow-up: Results of the European Heart Rhythm Association survey. Europace 2012;14:423-5.
39. Afolabi BA, Kusumoto FM. Remote monitoring of patients with implanted cardiac devices-a review. Eur Cardiol, 2012;8:88-93.
40. Laleci G, Dogac A, Yuksel M, Kabak Y, Arbelo E, Danmayr F et al. The personalized remote monitoring of the atrial fibrillation patients with electronic implant devices. J Healthc Eng 2011;2:183-96. http://multi-science. metapress.com/content/ b42106337r637111/fulltext.pdf
41. Vinck I,DeLaet C, Stroobandt S, Van Brabandt H. Legal and organizational aspects of remote cardiac monitoring: The example of implantable cardioverter defibrillators. Europace 2012;14:1230-5.
42. Ricci RP, D'Onofrio A, Padeletti L, Sagone A, Vicentini A, Vincenti A et al. Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF. Europace 2012;14:1661-5.
43. Papavasileiou LP, Forleo GB, Panattoni G, Schirripa V, Minni V, Magliano G et al. Work burden with remote monitoring of implantable cardioverter defibrillator: Is it time for reimbursement policies? J Cardiovasc Med (Hagerstown) 2013;14:114-9.
44. van HemelNM. Remote monitoring of implanted cardiac devices: A plea for a nationwide exploration. Neth Heart J 2009;17:434-7.
45. Kielstra P. Future-proofingWestern Europe?s healthcare: A study of five countries, Economist Intelligence Unit. 2011. http://www.eucomed.org/medical- technology/ futureproofing-western-eu-s-healthcare (accessed 11 March 2012).
46. Fornell D. Cardiology smart phone apps speed workflow, improve outcomes, diagnostic cardiology, 2013. pp. 30-4.